dc.contributor.author | Semchenko, Evgeny A | |
dc.contributor.author | Seib, Kate L | |
dc.date.accessioned | 2021-11-10T23:38:45Z | |
dc.date.available | 2021-11-10T23:38:45Z | |
dc.date.issued | 2021 | |
dc.identifier.issn | 1759-4812 | |
dc.identifier.doi | 10.1038/s41585-021-00534-5 | |
dc.identifier.uri | http://hdl.handle.net/10072/409794 | |
dc.description.abstract | Multidrug-resistant Neisseria gonorrhoeae is a global health problem, and the development of a vaccine is considered essential for the effective control of gonorrhoea. The use of outer membrane vesicle vaccines to prevent N. gonorrhoeae infection has garnered considerable interest, and a recent study using a mouse model of experimental gonococcal infections adds support for this approach. | |
dc.description.peerreviewed | Yes | |
dc.language | eng | |
dc.publisher | Springer Science and Business Media LLC | |
dc.relation.ispartofjournal | Nature reviews urology | |
dc.subject.fieldofresearch | Clinical sciences | |
dc.subject.fieldofresearchcode | 3202 | |
dc.title | Outer membrane vesicle vaccines for Neisseria gonorrhoeae | |
dc.type | Journal article | |
dc.type.description | C1 - Articles | |
dcterms.bibliographicCitation | Semchenko, EA; Seib, KL, Outer membrane vesicle vaccines for Neisseria gonorrhoeae, Nature reviews urology, 2021 | |
dc.date.updated | 2021-11-04T02:05:47Z | |
dc.description.version | Accepted Manuscript (AM) | |
gro.description.notepublic | This publication has been entered as an advanced online version in Griffith Research Online. | |
gro.rights.copyright | © 2021 Nature Publishing Group. This is the author-manuscript version of this paper. Reproduced in accordance with the copyright policy of the publisher. Please refer to the journal website for access to the definitive, published version. | |
gro.hasfulltext | Full Text | |
gro.griffith.author | Seib, Kate | |
gro.griffith.author | Semchenko, Evgeny | |